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Lascano E, Negroni J, Vila Petroff M, Mattiazzi A. Impact of
RyR2 potentiation on myocardial function. Am J Physiol Heart Circ
Physiol 312: H1105–H1109, 2017. First published April 7, 2017;
doi:10.1152/ajpheart.00855.2016.—This perspective attempts to shed
light on an old and not yet solved controversy in cardiac physiology,
i.e., the impact of increasing ryanodine receptor (RyR)2 open proba-
bility on myocardial function. Based on an already proven myocyte
model, it was shown that increasing RyR2 open probability results in
a purely short-lived increase in Ca21 transient amplitude, and, there-
fore, it does not increase cardiac contractility. However, potentiation
of RyR2 activity permanently enhances fractional Ca21 release,
shifting the intracellular Ca21 transient versus sarcoplasmic reticulum
(SR) Ca21 content curve to a new state of higher efficiency. This
would allow the heart to maintain a given contractility despite a
decrease in SR Ca21 content, to enhance contractility if SR Ca21
content is simultaneously preserved or to successfully counteract the
effects of a negative inotropic intervention.
NEW & NOTEWORTHY Increasing ryanodine receptor (RyR)2
open probability does not increase cardiac contractility. However,
RyR2 potentiation shifts the intracellular Ca21 transient-sarcoplasmic
reticulum (SR) Ca21 content relationship toward an enhanced effi-
ciency state, which may contribute to a positive inotropic effect,
preserve contractility despite decreased SR Ca21 content, or success-
fully counteract the effects of a negative inotropic action.
heart; contractility; ryanodine receptor; open probability
“. . . it has not been generally appreciated that a single Starling
curve cannot always satisfactorily explain the observed phenom-
ena; for any given heart there is a series or family of curves.”
Sarnoff and Berglund, 1954 (26)
SARCOLEMMAL DEPOLARIZATION during each cardiac cycle initi-
ates cardiac excitation-contraction coupling (ECC): Ca21 in-
flux through voltage-gated L-type Ca21 channel current (ICa)
activates ryanodine receptor (RyR)2 Ca21-release channels in
the sarcoplasmic reticulum (SR), allowing the release of a
much large amount of Ca21 from the SR into the cytosol via
the Ca21-induced Ca21-release (CICR) mechanism (9). This
mechanism gives rise to a transitory increase in intracellular
Ca21 (Ca21 transient) that signals contractile myofilaments to
generate force and shortening. Relaxation occurs when Ca21
returns to the diastolic Ca21 level, mainly due to the termina-
tion of SR Ca21 release in association with the activity of
sarco(endo)plasmic reticulum Ca21-ATPase (SERCA)2a and,
to a lesser extent, the sarcolemma Na1/Ca21 exchanger (NCX)
working in the forward mode (1, 5).
The CICR mechanism is therefore essentially an amplifying
process by which a modest Ca21 triggering signal is signifi-
cantly magnified. This is often referred to as gain (18, 28), i.e.,
the ratio between SR Ca21 released and ICa. Moreover, for a
given Ca21 triggering signal, the SR releases a fraction of its
Ca21 content [fractional SR Ca21 release (FCaR)], which has
been shown to be dependent on SR Ca21 load (18). Together
with ECC gain, FCaR has been used as a complementary
numerical index of ECC efficacy (10). Whereas an increase in
either ICa or SR Ca21 content are well-established positive
inotropic mechanisms (16, 17, 27, 35), the increase in the open
probability (Po) of RyR2 cannot be easily related to an im-
provement in cardiac function. This is in part because assess-
ment of the functional outcome of RyR2 potentiation in intact
cells is challenging. For instance, the simultaneous increase in
ICa and SR Ca21 uptake and load produced by b-adrenoceptor
(b-AR) stimulation (10, 16) will independently increase SR
Ca21 release, hampering the dissection of the contribution of
RyR2 phosphorylation per se, if any, to the positive inotropic
action of b-AR stimulation. To circumvent this problem, SR
Ca21 load and ICa have to be maintained constant (10, 18). The
general outcome of this type of experiments indicates that
whereas PKA-dependent phosphorylation of RyR2 has little
effect on ECC in a physiological milieu, Ca21/calmodulin-
dependent protein kinase (CaMK)II-dependent phosphorylation
of RyR2 increases Ca21-release channel activity in intact cardiac
myocytes during ECC. This phosphorylation “. . . would produce
a change in the sensitivity of the RyR2 to activation by Ca21, such
that a greater SR Ca21 efflux occurs for a given ICa” (18). These
conclusions are important, because they suggest a functional role
of RyR2 phosphorylation in addition to the recognized detrimen-
tal effect of CaMKII-dependent phosphorylation-induced passive
SR Ca21 leak and arrhythmia susceptibility (8, 22, 33).
To further assess this issue, we used an already proven
human myocyte mathematical model in which the effect of an
increase in RyR2 Po on myocardial function was mimicked by
increasing RyR2 conductance (22). The model faithfully re-
produces the experimental behavior of myocytes from wild-
type (WT) mice and myocytes from S2814D mice, with in-
creased Po produced by constitutive pseudo-phosphorylation of
RyR2 Ser2814 (33). Figure 1 shows that increasing RyR2
conductance by 50% did not have a sustained effect on the
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systolic Ca21 transient. Effectively, and similarly to previous
findings obtained with the application of low caffeine concen-
trations to modestly increase RyR2 Po (12, 32), it resulted in a
purely short-lived increase in Ca21 transient amplitude, in such
a way that, when the steady state is reached, the amplitude of
the Ca21 transient is virtually identical to that observed under
control conditions, even though the increase in the RyR2 Po is
still present. As noted by different reports by Greensmith et al.
(12) and Trafford et al. (32), our model indicates that the
temporary increase in Ca21 transient when the enhanced RyR2
conductance is applied results in decreased Ca21 entry into the
cell and increased Ca21 efflux, producing the subsequent drop
in both, SR Ca21 content and the systolic Ca21 transient.
Notably, and as shown in Fig. 1C, RyR2 potentiation enhanced
FCaR in association with the brief increase of the Ca21
transient. After increasing, FCaR decreased by ~50% and
remained at this intermediate value, higher than control, until
the effect of high Po was removed. This occurred despite the
fact that SR Ca21 load decreased below the levels observed
before RyR2 potentiation. Indeed, experiments in myocytes
from the above-mentioned Ser2814D mice exhibited enhanced
FCaR compared with WT mice for a similar SR Ca21 load (22,
33). These findings indicate that the increase in Po certainly
produces an ephemeral effect on Ca21 transients and it there-
fore fails to induce a sustained increase in contractility. How-
ever, it evokes a long-lasting effect on the systolic SR Ca21-
release mechanism, such that, for a given SR Ca21 content, the
SR Ca21 release is increased. The heart becomes more effi-
cient. Is this effect meaningful in the scenario of cardiac
function and inotropism?
Let’s make a digression from the ECC and consider for a
moment the typical family of Sarnoff’s ventricular function
curves schematically shown in Fig. 2A. The “normal” curve
depicts how cardiac systolic work increases with left ventric-
ular end-diastolic pressure, taken as an index of resting fiber
length (Frank-Starling mechanism). The other two curves
(dashed lines) represent a different condition of the heart, in
this case a condition of higher and lower inotropic state. An
increase in inotropism at a given resting (diastolic) length
occurs when going from point A to point B (vertical arrow) in
Fig. 2A. The increase in cardiac output would decrease dia-
stolic volume (length), and the ventricular work would shift
according to Starling’s law to point C or point D (horizontal
arrow) in Fig. 2A. In the latter case, the inotropic state would
increase without detectable increases in ventricular work (26).
Figure 2B shows the nonlinear relationship between the
magnitude of the systolic Ca21 transient and SR Ca21 content
under physiological “normal” conditions according to the
model. This relationship (blue line in Fig. 2B), in which the
magnitude of the Ca21 transient increases proportionately
more than the SR Ca21 content, is comparable with previously
reported experimental data (31). The red line in Fig. 2B shows
a similar relationship in a myocyte with a 50% increase in
RyR2 conductance. The effect of increasing Po produced an
upward and leftward shift of the curves. On these curves, we
can represent the sequential effect of increasing RyR2 Po. The
vertical arrow, from point A to point B (in Fig. 2B), indicates
the increase in Ca21 transient produced by an increase in Po.
The Ca21 transient would then decrease, following the red
curve (dashed arrow in Fig. 2B), according to the decrease in
SR Ca21 content reaching the same control Ca21 transient
level (point C). Following a criterion similar to that used with
the ventricular function curves, one may conclude that both
curves represent different functional states of the heart, such
that for a given SR Ca21 content, the release of Ca21 is greater
in the curve that represents the increased RyR2 Po.
We believe that the concept may be relevant and not simply
semantic, since it may help to clarify and dissect the contribu-
tion to cardiac function inherent to an increase in the activity of
RyR2 per se in the experimental setting. For instance, we can
consider, first, the aforementioned condition of an enhanced
CaMKII-dependent phosphorylation of RyR2 (S2814D). In
this case, previous reports (22, 33) found that FCaR was higher
versus WT myocytes, whereas the amplitude of the Ca21
transient was similar to WT levels despite the decrease in SR
Ca21 content. These results strongly suggest that S2814D
myocytes can reach WT Ca21 transient amplitude due to the
increase in RyR2 Po produced by CaMKII phosphorylation.
Otherwise, their contractility would be lower. Second, there is
the situation of a negative inotropic effect associated with an
increase in RyR2 Po. For instance, it has been shown that the
negative inotropic effect induced by hypotonic stress (HS) is
exacerbated in the presence of inhibition of the cGMP/PKG
Fig. 1. Time course of sarcolemmal and sarcoplasmic reticulum (SR) Ca21
fluxes produced by increased ryanodine receptor (RyR)2 open probability (Po).
A: intracellular Ca21 transient. B: SR Ca21 content. C: fractional SR Ca21
release (FCaR), Ca21 efflux, and Ca21 influx. The bar indicates the interval in
which Po was increased (1Po). [Ca21]i, intracellular Ca21 concentration;
[Ca21]SR, SR Ca21 concentration.
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pathway, which, during HS, is responsible for PKG-dependent
phosphorylation of RyR2, sensitizing RyR2 to Ca21 (11). In
this case, the increase in SR Ca21 release produced by this
phosphorylation occurs despite the lack of significant changes
in SR Ca21 load (11) and the well-known decrease in ICa
produced by HS (6, 20). This effect would counteract the
negative inotropic action of HS, which would have been
greater in the absence of RyR2 phosphorylation. Supporting
this concept, Ho et al. (13) recently demonstrated that cholin-
ergic stimulation of the heart produced an increase in SR Ca21
release at low SR Ca21 content compared with nonstimulated
hearts. The consequent enhancement of FCaR, which occurs
without alterations of ICa, is due to a facilitation of SR Ca21
release produced by PKG-dependent phosphorylation of RyR2
at the Ser2808 site. The authors emphasized that this mechanism
may be beneficial in failing hearts by preserving enhanced
systolic release, counteracting, therefore, the heart failure-
induced decrease in contractility. This type of result under-
scores again the importance of RyR2 Po as an active regulator
of cardiac function.
In this context, it is important to point out that more
substancial increases in RyR2 Po than that considered above
may also occur. For instance, it has been shown that caffeine
concentrations of $1 mM decrease Ca21 transients (25). Also,
in advanced heart failure, RyR2 has been described to be
locked in a subconductance state (21), and enhanced RyR2-
mediated Ca21 leak has been shown to diminish intracellular
Ca21 transients (3). Moreover, reducing SR Ca21 leak normal-
izes Ca21 transient amplitude (15, 29). These results reveal that
under these conditions, the expected Ca21 flux balance that
produces transitory effects on intracellular Ca21 transients (12,
32) is not operative. Indeed, in overt heart failure, the severe
decrease in SR Ca21 would highly hamper the CICR mecha-
nism (2, 5, 14). When in our model RyR2 conductance was
increased to 100%, a decrease in the intracellular Ca21 tran-
sient of ~20% was observed. Interestingly, even under these
conditions, FCaR was still higher than control.
b-AR stimulation is also a particular case of an increase in
RyR2 Po that occurs associated with an increase in ICa and
accelerated SERCA2a-mediated SR Ca21 uptake. As shown in
Fig. 2C, we simulated an increase in SR Ca21 uptake of 30%
and of ICa of 30%, which would mimic the effects of a low
isoproterenol concentration, according to experimental data (7,
19) and a recently published model (23). As expected, there
was a shift of the “control” point (point A in Fig. 2C) toward
higher SR Ca21 concentrations (point B in Fig. 2C). At this
point, increasing RyR2 conductance by 15% and 25% tran-
siently increased intracellular Ca21 transients due to the in-
crease in Po, from point B to point C and point D in Fig. 2C,
respectively. The Ca21 transient then decreased (dashed arrow)
according to the decrease in SR Ca21 content, reaching values
similar to point B (points C= and D=) but higher than point A
(Fig. 2C), mimicking the positive inotropy of b-AR stimula-
tion. Greater increases in RyR2 conductance, i.e, 50%, were
associated in the model with the development of arrhythmias.
This result indicates that the flux balance triggered by the
opening of RyR2 (12, 31) also takes place under isoproterenol
stimulation. Again, for a given SR Ca21 load, the increase in
RyR2 Po results in an enhanced FCaR.
Finally, it is important to emphasize that the above
analysis does not attempt to underestimate the negative
influence of increasing RyR2 Po on myocardial function due
the enhancement of diastolic Ca21 leak. In addition to the
decrease in SR Ca21 content, which necessarily affects
Ca21 transient amplitude, an increase in SR Ca21 leak
would increase diastolic Ca21 and slow relaxation, leading
to diastolic dysfunction and Ca21-triggered arrhythmias, as
has been shown as a consequence of RyR2 mutations/
phosphorylation and at different stages of heart failure (3, 4,
22, 33, 34). Indeed, experimental evidence indicates that the
RyR2 stabilizer JTV519 reduces RyR2 Po and protects
nonfailing and terminally failing human myocardium from
diastolic dysfunction induced by SR Ca21 overload (24, 30).
These unfavorable actions of the increase in SR Ca21 leak
Fig. 2. A: typical Sarnoff ventricular function curves. Normal represents the control curve. LVSW, left ventricular systolic work; LVEDP, left ventricular
end-diastolic pressure. B: steady-state peak [Ca21]i as a function of [Ca21]SR. Arrows represent the sequential changes in SR Ca21 load and Ca21 transients after
increasing RyR2 conductance by 50% under basal conditions, as described in Fig. 1. C: sequential changes in Ca21 transients during b-adrenoceptor stimulation.
Increasing L-type Ca21 channel current and sarco(endo)plasmic reticulum Ca21-ATPase 2a activity increased SR Ca21 load and the Ca21 transient from point
A to point B. Arrows from points B to C and C= and D and D= represent the successive changes in Ca21 transients after increasing Po by 15% and 25%,
respectively.
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on cardiac function, which may prevail in the later stages of
heart failure, would oppose and even eclipse the beneficial
effects of RyR2 potentiation on systolic Ca21 release. How-
ever, and as already discussed, these latter effects would
contribute to either increase or maintain cardiac function
under different conditions, including early stages of heart
failure, despite enhanced diastolic Ca21 leak (4).
In summary, the above considerations emphasize that the
increase in Po of RyR2 may be functional and would actively
contribute to define a given inotropic state, counteracting their
own detrimental effects on cardiac function.
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